Fibulin-2 is an extracellular matrix inhibitor of oligodendrocytes relevant to multiple sclerosis
Journal of Clinical Investigation · 2024
DOI: 10.1172/jci176910 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Samira Ghorbani und 13 weiteren Autor:innen. Beteiligte Einrichtung: Hotchkiss Brain Institute and Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Calcium-Binding Proteins, Encephalomyelitis, Autoimmune, Experimental, Extracellular Matrix, Extracellular Matrix Proteins. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Defense (DOD) grant, Multiple Sclerosis Canada, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Impairment of oligodendrocytes and myelin contributes to neurological disorders including multiple sclerosis (MS), stroke, and Alzheimer’s disease. Regeneration of myelin (remyelination) decreases the vulnerability of demyelinated axons, but this repair process commonly fails with disease progression. A contributor to inefficient remyelination is the altered extracellular matrix (ECM) in lesions, which remains to be better defined. We have identified fibulin-2 (FBLN2) as a highly upregulated ECM component in lesions of MS and stroke and in proteome databases of Alzheimer’s disease and traumatic brain injury. Focusing on MS, the inhibitory role of FBLN2 was suggested in the experimental autoimmune encephalomyelitis (EAE) model, in which genetic FBLN2 deficiency improved behavioral recovery by promoting the maturation of oligodendrocytes and enhancing remyelination. Mechanistically, when oligodendrocyte progenitors were cultured in differentiation medium, FBLN2 impeded their maturation into oligodendrocytes by engaging the Notch pathway, leading to cell death. Adeno-associated virus deletion of FBLN2 in astrocytes improved oligodendrocyte numbers and functional recovery in EAE and generated new myelin profiles after lysolecithin-induced demyelination. Collectively, our findings implicate FBLN2 as a hitherto unrecognized injury-elevated ECM, and a therapeutic target, that impairs oligodendrocyte maturation and myelin repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hotchkiss Brain Institute and Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
- Department of Biology, University of Toronto Mississauga, Mississauga, Ontario, Canada.
- Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
- Department of Biochemistry, Microbiology, and Immunology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
- Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Division of Medical Sciences, University of Victoria, Victoria, British Columbia, Canada.
Förderung
- Department of Defense (DOD) grant
- Multiple Sclerosis Canada
- Canadian Institutes of Health Research
Zitieren
APA
Ghorbani, S., Li, C., Lozinski, B. M., Moezzi, D., D'Mello, C., Dong, Y., Visser, F., Li, H., Silva, C., Khakpour, M., Murray, C. J., Tremblay, M. È., Xue, M., & Yong, V. W. (2024). Fibulin-2 is an extracellular matrix inhibitor of oligodendrocytes relevant to multiple sclerosis. Journal of Clinical Investigation. https://doi.org/10.1172/jci176910
Vancouver
Ghorbani S, Li C, Lozinski BM, Moezzi D, D'Mello C, Dong Y, et al. Fibulin-2 is an extracellular matrix inhibitor of oligodendrocytes relevant to multiple sclerosis. Journal of Clinical Investigation. 2024. doi:10.1172/jci176910
BibTeX
@article{Ghorbani2024,
author = {Ghorbani, Samira and Li, Cenxiao and Lozinski, Brian M and Moezzi, Dorsa and D'Mello, Charlotte and Dong, Yifei and Visser, Frank and Li, Hongmin and Silva, Claudia and Khakpour, Mohammadparsa and Murray, Colin J and Tremblay, Marie-Ève and Xue, Mengzhou and Yong, V Wee},
title = {Fibulin-2 is an extracellular matrix inhibitor of oligodendrocytes relevant to multiple sclerosis},
journal = {Journal of Clinical Investigation},
year = {2024},
doi = {10.1172/jci176910}
}
EUVIMED